17,588 reports of this reaction
7.3% of all Symbicort reports
#1 most reported adverse reaction
DYSPNOEA is the #1 most commonly reported adverse reaction for Symbicort, manufactured by AstraZeneca Pharmaceuticals LP. There are 17,588 FDA adverse event reports linking Symbicort to DYSPNOEA. This represents approximately 7.3% of all 240,442 adverse event reports for this drug.
Patients taking Symbicort who experience dyspnoea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DYSPNOEA is moderately reported among Symbicort users, representing a notable but not dominant share of adverse events.
In addition to dyspnoea, the following adverse reactions have been reported for Symbicort:
The following drugs have also been linked to dyspnoea in FDA adverse event reports:
DYSPNOEA has been reported as an adverse event in 17,588 FDA reports for Symbicort. This does not prove causation, but indicates an association observed in post-market surveillance data.
DYSPNOEA accounts for approximately 7.3% of all adverse event reports for Symbicort, making it one of the most commonly reported side effect.
If you experience dyspnoea while taking Symbicort, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.